Thermo Fisher Scientific Inc


Want a discount? Become a member by purchasing Annual Subscription!
SKU: TMO Category:


Thermo Fisher Scientific is a well-known name in the pharmaceutical and biotech industries that has witnessed remarkable growth in 2020, leveraging on its capacity to extend support amid pandemic. The company saw robust growth across all its businesses including BioProduction, Pharma Services, Biosciences, and the company’s Research and Safety Market Channel. Thermo’s ability to rapidly scale up manufacturing to support the volumes needed enabled the company to conduct Covid-19 testing at an unprecedented level. Moreover, the company established a joint venture to set up biological drug development and manufacturing in China on account of focussing on organic growth of its bioproduction, pharma services, and biosciences businesses. The management also announced plans to make plasmid DNA for cell and gene therapies in California. Such actions make us optimistic that Thermo Fisher is not resting on its upward trajectory from fighting Covid in 2020 but is capitalizing on it further to drive future growth.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $496 annual subscription!